| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0009-3084(02)00162-7 |
| P698 | PubMed publication ID | 12505706 |
| P2093 | author name string | Eliot L Gardner | |
| P2860 | cites work | Addictive Drugs and Brain Stimulation Reward | Q22241983 |
| Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment | Q48611417 | ||
| Getting the brain's attention | Q48613454 | ||
| A neural substrate of prediction and reward | Q27860851 | ||
| Phasic accumbal firing may contribute to the regulation of drug taking during intravenous cocaine self-administration sessions | Q28369513 | ||
| The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 | ||
| Drug abuse: hedonic homeostatic dysregulation | Q29615904 | ||
| What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? | Q29618655 | ||
| The reverse transport of DA, what physiological significance? | Q31804333 | ||
| Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system | Q32065101 | ||
| Is the short-latency dopamine response too short to signal reward error? | Q33594395 | ||
| Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies | Q33662343 | ||
| Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens | Q33667218 | ||
| Mesolimbic neuronal activity across behavioral states | Q33692739 | ||
| Opioid modulation of ventral pallidal inputs | Q33692766 | ||
| Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. | Q33692830 | ||
| The role of the striatopallidal and extended amygdala systems in drug addiction | Q33692839 | ||
| What we have learned about addiction from animal models of drug self-administration | Q34129906 | ||
| Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry | Q34176404 | ||
| Reinstatement of cocaine-reinforced responding in the rat. | Q34269959 | ||
| Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex | Q34378202 | ||
| Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra | Q34421920 | ||
| Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate | Q34440550 | ||
| Neurobiology of relapse to heroin and cocaine seeking: a review | Q34547387 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis | Q34631075 | ||
| Mesolimbic dopaminergic decline after cannabinoid withdrawal | Q34750833 | ||
| Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol | Q35028253 | ||
| Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats | Q35041427 | ||
| Marijuana's interaction with brain reward systems: update 1991. | Q37028121 | ||
| Genetic approaches to the analysis of addiction processes | Q38629083 | ||
| The analgesic properties of delta-9-tetrahydrocannabinol and codeine | Q39336497 | ||
| A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouse | Q39609704 | ||
| Pretreatment with δ1-tetrahydrocannabinol and psychoactive drugs: Effects on uptake of biogenic amines and on behavior | Q40285531 | ||
| Self-administration of Δ9-tetrahydrocannabinol by rats | Q40290487 | ||
| Molecular Mechanisms of Drug Reinforcement and Addiction | Q40441120 | ||
| The role of dopamine in drug abuse viewed from the perspective of its role in motivation | Q40480641 | ||
| Substance abuse vulnerability and D2 receptor genes | Q40485679 | ||
| Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. | Q40887711 | ||
| Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal | Q40890918 | ||
| Drug addiction: the yin and yang of hedonic homeostasis | Q40986691 | ||
| Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy | Q41104016 | ||
| Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis study | Q41130886 | ||
| THC does not affect striatal dopamine release: Microdialysis in freely moving rats | Q41141136 | ||
| Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. | Q48631827 | ||
| Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area | Q48663508 | ||
| Anatomically distinct opiate receptor fields mediate reward and physical dependence | Q48670096 | ||
| The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference | Q48691693 | ||
| Morphine-induced activation of A10 dopamine neurons in the rat | Q48724061 | ||
| Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects | Q48725501 | ||
| A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain | Q48839891 | ||
| Decreases in dopamine receptors but not in dopamine transporters in alcoholics | Q48846413 | ||
| Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex | Q48859883 | ||
| Drug reinforcement studied by the use of place conditioning in rat | Q48922550 | ||
| Brain reward circuitry: four circuit elements "wired" in apparent series | Q49023765 | ||
| An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. | Q51139556 | ||
| Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. | Q51375099 | ||
| Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse. | Q51410495 | ||
| Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. | Q51526229 | ||
| Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. | Q51555875 | ||
| Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. | Q51615260 | ||
| Drug policy: striking the right balance. | Q51726962 | ||
| Epidemiology of drug abuse: an overview. | Q51800436 | ||
| Cannabinoid receptors and reward in the rat: a conditioned place preference study. | Q52165794 | ||
| A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. | Q52170981 | ||
| Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. | Q52187770 | ||
| Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. | Q52196139 | ||
| Aversive effects of the synthetic cannabinoid CP 55,940 in rats. | Q52202419 | ||
| Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. | Q52203929 | ||
| Reward shifts and motor responses following microinjections of opiate-specific agonists into either the core or shell of the nucleus accumbens. | Q52207638 | ||
| THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. | Q52210365 | ||
| Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. | Q52211526 | ||
| Conditioned aversion after delay place conditioning with amphetamine. | Q52242882 | ||
| Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. | Q52248376 | ||
| Interactions between the amygdala and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement. | Q52248378 | ||
| Rat strain differences in ethanol self-administration and taste aversion learning. | Q52255289 | ||
| Genetic and environmental factors in ethanol self-administration. | Q52256204 | ||
| Pharmacologic characterization of nicotine-induced conditioned place preference. | Q52268923 | ||
| Drug reinstatement of heroin-reinforced responding in the rat. | Q52284623 | ||
| Lithium chloride and delta-9-THC lead to conditioned aversions in the pigeon. | Q52296084 | ||
| The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. | Q55331780 | ||
| Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey | Q56771822 | ||
| A portrait of the substrate for self-stimulation | Q57091743 | ||
| A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior | Q68020687 | ||
| Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts | Q68776709 | ||
| Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys | Q68790350 | ||
| Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation | Q69739988 | ||
| The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study | Q69853528 | ||
| Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist | Q70911264 | ||
| Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral Administration | Q70976547 | ||
| Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain | Q73101567 | ||
| Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum | Q73669937 | ||
| Burst firing in midbrain dopaminergic neurons | Q74293267 | ||
| Neural basis of utility estimation | Q41463705 | ||
| Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. | Q41644150 | ||
| Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis | Q41680193 | ||
| Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. | Q41690992 | ||
| Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal | Q42277951 | ||
| The effect of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats | Q42443179 | ||
| Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient | Q42502076 | ||
| Modulation of rat brain cannabinoid receptors after chronic morphine treatment | Q42546895 | ||
| Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues | Q43070521 | ||
| Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain | Q43542613 | ||
| Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2. | Q43562046 | ||
| Relapse to cocaine-seeking after hippocampal theta burst stimulation | Q43604854 | ||
| Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine | Q43617622 | ||
| Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system | Q43678414 | ||
| Overexpression of dopamine D2 receptors reduces alcohol self-administration | Q43735216 | ||
| A cannabinoid mechanism in relapse to cocaine seeking. | Q43759232 | ||
| Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex | Q43812676 | ||
| Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats | Q43826362 | ||
| Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats | Q44086486 | ||
| Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal | Q44342597 | ||
| delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
| Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 | ||
| Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey | Q44429030 | ||
| Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response | Q44465384 | ||
| Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli | Q44768643 | ||
| Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys | Q44879831 | ||
| Aversion instead of preference learning indicated by nicotine place conditioning in rats | Q44918479 | ||
| Effects of body weight levels on Cannabis self-injection | Q47289171 | ||
| Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance | Q47893448 | ||
| Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice | Q47987506 | ||
| Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice | Q47994629 | ||
| Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice | Q48087712 | ||
| The effect of chronic cocaine on self-stimulation train-duration thresholds | Q48089287 | ||
| Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro | Q48127886 | ||
| Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol | Q48141521 | ||
| Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol | Q48163060 | ||
| The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis | Q48187138 | ||
| Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine | Q48205587 | ||
| Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal | Q48267210 | ||
| Nicotinic effects on the firing pattern of midbrain dopamine neurons | Q48279649 | ||
| Cannabinoid transmission and reward-related events | Q48285165 | ||
| CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats | Q48327876 | ||
| Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids | Q48383234 | ||
| Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system | Q48415040 | ||
| Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats | Q48419154 | ||
| Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons | Q48428303 | ||
| Cannabinoid receptors and their endogenous agonists | Q48464429 | ||
| Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices | Q48465187 | ||
| Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors | Q48518726 | ||
| Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains | Q48540143 | ||
| Opioids excite dopamine neurons by hyperpolarization of local interneurons | Q48543154 | ||
| Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex | Q48574685 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | cannabinoids | Q422936 |
| P304 | page(s) | 267-290 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Chemistry and Physics of Lipids | Q15746139 |
| P1476 | title | Addictive potential of cannabinoids: the underlying neurobiology | |
| P478 | volume | 121 |
| Q38036236 | A brain on cannabinoids: the role of dopamine release in reward seeking |
| Q35842989 | A genome-wide scan for loci influencing adolescent cannabis dependence symptoms: evidence for linkage on chromosomes 3 and 9. |
| Q48009861 | Acetaldehyde oral self-administration: evidence from the operant-conflict paradigm |
| Q55002265 | Adolescent THC exposure does not sensitize conditioned place preferences to subthreshold d-amphetamine in male and female rats. |
| Q28270110 | Agents in development for the management of cocaine abuse |
| Q33980198 | Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future |
| Q37760048 | Cannabinoid conditioned reward and aversion: behavioral and neural processes. |
| Q44885114 | Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. |
| Q24633884 | Cannabinoids in health and disease |
| Q36358688 | Cannabis reward: biased towards the fairer sex? |
| Q44925266 | DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine |
| Q37351714 | Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk |
| Q44845267 | Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade |
| Q24814542 | Harm reduction--the cannabis paradox |
| Q46460331 | In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Delta-tetrahydrocannabinol |
| Q36873051 | Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. |
| Q48164825 | Intra-accumbal Cannabinoid Agonist Attenuated Reinstatement but not Extinction Period of Morphine-Induced Conditioned Place Preference; Evidence for Different Characteristics of Extinction Period and Reinstatement |
| Q37087794 | Lack of behavioral sensitization after repeated exposure to THC in mice and comparison to methamphetamine |
| Q48374981 | Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison |
| Q24671514 | Marijuana and cannabinoid regulation of brain reward circuits |
| Q21090461 | Marijuana: current concepts(†) |
| Q52674788 | Mechanisms Underlying Sex Differences in Cannabis Use. |
| Q28078759 | Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? |
| Q33496528 | Reactivity to cannabis cues in virtual reality environments |
| Q41863571 | Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain |
| Q46919279 | Short- and long-term consequences of prenatal exposure to cannabis |
| Q64229781 | The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder |
| Q46431172 | The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. |
| Q35193287 | The case for peripheral CB₁ receptor blockade in the treatment of visceral obesity and its cardiometabolic complications |
| Q36434442 | The role of the endocannabinoid system in the control of energy homeostasis. |
Search more.